184 related articles for article (PubMed ID: 11450161)
1. [Clinical pharmacology of angiotensin II receptor antagonists].
Hitzenberger G
Wien Med Wochenschr; 2001; 151(7-8):151-2. PubMed ID: 11450161
[TBL] [Abstract][Full Text] [Related]
2. [Therapeutic perspectives: association of ACE inhibitors and angiotensin receptor blockers].
Costantino S; Millozzi F; Scarlata S
Clin Ter; 2001; 152(2):77-8. PubMed ID: 11441526
[No Abstract] [Full Text] [Related]
3. [Angiotensin II type-1-receptor antagonists from the viewpoint of nephrology].
Hauser AC; Hörl WH
Wien Med Wochenschr; 2001; 151(7-8):160-4. PubMed ID: 11450164
[TBL] [Abstract][Full Text] [Related]
4. Angiotensin receptor blockers: pharmacology and clinical significance.
Mimran A; Ribstein J
J Am Soc Nephrol; 1999 Apr; 10 Suppl 12():S273-7. PubMed ID: 10201882
[TBL] [Abstract][Full Text] [Related]
5. [Pathophysiological and clinical implications of AT(1) and AT(2) angiotensin II receptors in essential hypertension].
Burnier M
Drugs; 2002; 62 Spec No 1():21-9. PubMed ID: 12036386
[TBL] [Abstract][Full Text] [Related]
6. [Concurrence to ACE inhibitors? AT1 receptor blockers and hypertension].
Heemann U; Kribben A; Phillip T
Pharm Unserer Zeit; 2001; 30(4):309-12. PubMed ID: 11499256
[No Abstract] [Full Text] [Related]
7. [The clinical pharmacology of angiotensin II antagonists].
Arabidze GG; Novikova LS
Farmakol Toksikol; 1990; 53(2):80-6. PubMed ID: 2369961
[TBL] [Abstract][Full Text] [Related]
8. Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in hypertension due to primary aldosteronism: a case for exclusion.
Bubbar CD; Blackburn DF; Wilson MP; Wilson TW
Ann Pharmacother; 2007 Jan; 41(1):129-32. PubMed ID: 17179189
[TBL] [Abstract][Full Text] [Related]
9. [Effect of angiotensin II and antagonists of the renin-angiotensin system on the cerebral circulation].
Adzhienko LM
Eksp Klin Farmakol; 2000; 63(4):74-9. PubMed ID: 11022315
[No Abstract] [Full Text] [Related]
10. [The therapy of arterial hypertension: a comparison between ACE inhibitors and angiotensin-II-receptor antagonists].
Rossi F; Mangrella M; Paternò E; Imperatore F; Capristo M; Imperatore C; Guarino A
Clin Ter; 1996 Oct; 147(10):475-88. PubMed ID: 9264900
[TBL] [Abstract][Full Text] [Related]
11. [Pharmacokinetic and pharmacodynamic aspects of angiotensin II antagonists. Focus on arterial hypertension].
da Silva PM
Rev Port Cardiol; 1998 Jun; 17(6):545-55. PubMed ID: 9677832
[TBL] [Abstract][Full Text] [Related]
12. [Clinical efficacy of losartan: are there any differences between angiotensin II type I receptor antagonists and other drugs?].
Redon J; Ferrario CM
Med Clin (Barc); 2000; 114 Suppl 1():23-8. PubMed ID: 10812571
[No Abstract] [Full Text] [Related]
13. [Combination therapy with ACE inhibitors and angiotensin receptor antagonists].
Kisters K
Internist (Berl); 1999 Jun; 40(6):678-9. PubMed ID: 10420325
[No Abstract] [Full Text] [Related]
14. [Angiotensin II antagonists versus ACE inhibitors in the treatment of raised blood pressure].
Andersen RS; Christensen S
Ugeskr Laeger; 2001 Dec; 163(50):7036-9. PubMed ID: 11794033
[TBL] [Abstract][Full Text] [Related]
15. Angiotensin II receptor antagonists role in arterial hypertension.
Hernández-Hernández R; Sosa-Canache B; Velasco M; Armas-Hernández MJ; Armas-Padilla MC; Cammarata R
J Hum Hypertens; 2002 Mar; 16 Suppl 1():S93-9. PubMed ID: 11986904
[TBL] [Abstract][Full Text] [Related]
16. [Pathophysiological and clinical implications of AT(1)/AT(2) angiotensin II receptors in heart failure and coronary and renal failure].
Sandmann S; Unger T
Drugs; 2002; 62 Spec No 1():43-52. PubMed ID: 12036388
[TBL] [Abstract][Full Text] [Related]
17. Combination therapy with ACE inhibitors/angiotensin II receptor antagonists and diuretics in hypertension.
Waeber B
Expert Rev Cardiovasc Ther; 2003 May; 1(1):43-50. PubMed ID: 15030296
[TBL] [Abstract][Full Text] [Related]
18. The angiotensin II receptor blockers: opportunities across the spectrum of cardiovascular disease.
Weber MA
Rev Cardiovasc Med; 2002; 3(4):183-91. PubMed ID: 12556752
[TBL] [Abstract][Full Text] [Related]
19. The comparative pharmacology of angiotensin II receptor antagonists.
Burnier M; Maillard M
Blood Press Suppl; 2001; 1():6-11. PubMed ID: 11333013
[TBL] [Abstract][Full Text] [Related]
20. Clinical potential: angiotensin converting enzyme inhibitor or angiotensin II antagonist?
McInnes GT
J Hypertens Suppl; 2001 Jun; 19(1):S61-7. PubMed ID: 11451217
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]